In vivo ACE inhibition has been demonstrated to be effective in reducing BP, since this enzyme synthetizes the vasoconstrictor angiotensin II (ANGII).[105] ANGII is a major contributor to hypertension via its central, vascular, and renal effects. This evidence concerns the gene AGT and Hypertension.